4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-20-024880
Chief Financial Officer acquired 2,500 shares (grant or award)
- Chief Financial Officer gave up 2,134 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bonner Michael Chief Financial Officer | 2020-03-18 | Shares withheld for taxes | −2,134 | $3.53 | $7,533 | 17,787 | D |
| Bonner Michael Chief Financial Officer | 2020-03-23 | Grant or award | +2,500 | $3.56 | $8,900 | 20,287 | D |
Loading xslF345X03/doc4.xml…